Xtx Topco LTD Eye Point Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $1.81 Billion
- Q1 2025
A detailed history of Xtx Topco LTD transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 43,740 shares of EYPT stock, worth $307,929. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,740Holding current value
$307,929% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding EYPT
# of Institutions
164Shares Held
71.6MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$58.6 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$47.9 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$43.6 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$29.2 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$28.8 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $240M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...